FutureFuel (FF) investor relations material

Executive summary

• Revenue rose 82% year-over-year to $31.95 million, driven by strong growth in both chemical and biofuel segments, with new energy market products, regulatory clarity, and new customer wins supporting gains.

• Net loss widened to $20.6 million, or $(0.47) per share, primarily due to derivative losses and non-recurring winter storm repair costs.

• Adjusted EBITDA improved to a loss of $13.8 million from a loss of $16.1 million, reflecting better underlying operating performance despite headline losses.

• New customer wins and a $25 million customer-funded capacity addition in Chemicals signal strong demand and asset optimization.

Financial highlights

• Revenue: $31.95 million (up 82% year-over-year); Chemical revenue: $19.6 million (+109.6% YoY); Biofuel revenue: $12.3 million (+50.7% YoY).

• Net loss: $20.6 million (vs. $18.1 million loss prior year); Loss per share: $(0.47) basic and diluted (vs. $(0.41) prior year).

• Adjusted EBITDA: $(13.8) million (improved from $(16.1) million prior year).

• Gross loss: $15.9 million (vs. $15.2 million prior year), impacted by $11.6 million in derivative losses and $3.2 million in storm-related impacts.

• Cash and cash equivalents: $22.4 million as of March 31, 2026, down from $51.3 million at year-end 2025.

Outlook and guidance

• Management anticipates positive Adjusted EBITDA for full-year 2026, excluding non-cash derivative timing differences.

• Over 65% of 2026 capital spending expected to be customer-funded, supporting capacity expansion and recurring revenue streams.

• Regulatory changes and new EPA blending mandates expected to drive improved demand and economics for Biofuels segment.

• Domestic capacity utilization expected to reach 100% by 2027.

• Anticipates ongoing volatility in biofuel markets due to commodity price swings and regulatory changes.